Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond.
Ellis
Chris J
CJ
Hamer
Andrew W
AW
D001315:Australia / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D016527:Drug Costs; D006292:Health Priorities; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D009520:New Zealand / Q000453:epidemiology; D017035:Pravastatin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin